{"id":"W2176098424","doi":"10.1016/j.bmcl.2004.11.021","title":"4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists","year":2004,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Chemistry; Piperazine; TRPV1; Antagonist; IC50; Benzimidazole; Capsaicin; Stereochemistry; Pharmacology; In vitro; Biochemistry; Receptor; Transient receptor potential channel; Organic chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002778441,0.0004204902,0.0004818796,0.0003313039,0.000271683,0.000304411,0.0005638631,0.0003610336,0.003327382],"category_scores_gemma":[0.0002086934,0.0002328859,0.0001764673,0.0002820771,0.0002289278,0.0003763199,0.000271683,0.0009888875,0.0007825404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004402095,"about_ca_system_score_gemma":0.0002928444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008201672,"about_ca_topic_score_gemma":0.004086109,"domain_scores_codex":[0.9998491,0.00003132763,0.00000858866,0.00001595597,0.00003159065,0.00006339288],"domain_scores_gemma":[0.9999523,0.00001061566,0.0000114824,0.000003932442,0.000006762618,0.00001488174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001331295,0.0002467595,0.0002075082,0.0005678168,0.00002926609,0.0002966505,0.000142893,0.001105984,0.9526675,0.003243676,0.002729064,0.03743149],"study_design_scores_gemma":[0.001847608,0.01169469,0.009034231,0.0001747678,0.0002251397,0.002089872,0.0001392165,0.005447666,0.8532668,0.001221057,0.1147522,0.0001068714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8698257,0.08187759,0.0132635,0.001812118,0.0007944126,0.0003486473,0.001047603,0.000840426,0.03019008],"genre_scores_gemma":[0.9504445,0.03150017,0.004086592,0.0004173513,0.0001743102,0.0001405447,0.0008211275,0.00004295607,0.0123726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003327382,"threshold_uncertainty_score":0.01113117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01380697168275361,"score_gpt":0.2378942708120587,"score_spread":0.2240872991293051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}